Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
43 hedge funds and large institutions have $4.58M invested in Chembio diagnostics, Inc. in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 13 closing their positions.
9% less funds holding
Funds holding: 47 → 43 (-4)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
54% less capital invested
Capital invested by funds: $9.94M → $4.58M (-$5.35M)
64% less call options, than puts
Call options by funds: $106K | Put options by funds: $298K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.03M |
| 2 |
EGM
Engineers Gate Manager
New York
|
+$275K |
| 3 |
VF
Virtu Financial
New York
|
+$203K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$202K |
| 5 |
Goldman Sachs
New York
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$877K |
| 2 |
RA
Royce & Associates
New York
|
-$361K |
| 3 |
PM
Penbrook Management
New York
|
-$323K |
| 4 |
Morgan Stanley
New York
|
-$210K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$137K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| – | -$6K | -2,359 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$2K | -896 | Closed |
|
53
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$1K | -500 | Closed |
|
|
FWM
54
Focused Wealth Management
Newburgh,
New York
| – | -$1K | -375 | Closed |
|
55
Bank of America
Charlotte,
North Carolina
| – | +$312 | +153 | New |
|
56
Fidelity Investments
Boston,
Massachusetts
| – | +$428 | +210 | +163% |
|
CEMI Hedge Fund Activity: Q4 2021 in Review
43 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2021, worth a combined $4.58M — down 54% from $9.94M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CEMI and 9 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 10 added.
The largest buyer was Vanguard Group, adding an estimated $1.03M. The largest seller was Segall Bryant & Hamill, exiting entirely with an estimated $877K sold.
- 43 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2021, down from 47 in Q3 2021.
- Funds reported $4.58M of Chembio diagnostics, Inc. stock for Q4 2021, down 54% quarter-over-quarter.
- 9 funds opened new Chembio diagnostics, Inc. positions in Q4 2021 and 13 closed out, a net change of -4 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2021 was Vanguard Group, an estimated $1.03M added.
- The largest Chembio diagnostics, Inc. seller in Q4 2021 was Segall Bryant & Hamill, an estimated $877K sold.
Based on aggregated 13F filings for Q4 2021.